Cargando…

Increasing the Efficiency of a National Laboratory Response to COVID-19: a Nationwide Multicenter Evaluation of 47 Commercial SARS-CoV-2 Immunoassays by 41 Laboratories

In response to the worldwide pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the subsequent antibody tests that flooded the market, a nationwide collaborative approach in the Netherlands was employed. Forty-one Dutch laboratories joined forces and shared their evaluation...

Descripción completa

Detalles Bibliográficos
Autores principales:	van den Beld, Maaike J. C., Murk, Jean-Luc, Kluytmans, Jan, Koopmans, Marion P. G., Reimerink, Johan, van Loo, Inge H. M., Wegdam-Blans, Marjolijn C. A., Zaaijer, Hans, GeurtsvanKessel, Corine, Reusken, Chantal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Virology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373020/ https://www.ncbi.nlm.nih.gov/pubmed/34191578 http://dx.doi.org/10.1128/JCM.00767-21

Ejemplares similares

Sensitivity of Detection and Variant Typing of SARS-CoV-2 in European Laboratories
por: Mögling, Ramona, et al.
Publicado: (2022)

Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical Laboratories
por: Harritshøj, Lene H., et al.
Publicado: (2021)

Comparison of Commercially Available and Laboratory-Developed Assays for In Vitro Detection of SARS-CoV-2 in Clinical Laboratories
por: Lieberman, Joshua A., et al.
Publicado: (2020)

Variable Sensitivity of SARS-CoV-2 Molecular Detection in European Expert Laboratories: External Quality Assessment, June and July 2020
por: Fischer, Carlo, et al.
Publicado: (2021)

Comparing Immunoassays for SARS-CoV-2 Antibody Detection in Patients with and without Laboratory-Confirmed SARS-CoV-2 Infection
por: Leuzinger, Karoline, et al.
Publicado: (2021)

Multi-laboratory evaluation of ReaScan TBE IgM rapid test, 2016 to 2017
por: Albinsson, Bo, et al.
Publicado: (2020)

Evaluation of commercial SARS-CoV-2 serological assays in Canadian public health laboratories
por: Stein, Derek R., et al.
Publicado: (2021)

Longitudinal evaluation of laboratory-based serological assays for SARS-CoV-2 antibody detection
por: Bond, K.A., et al.
Publicado: (2021)

The widely distributed hard tick, Haemaphysalis longicornis, can retain canine parvovirus, but not be infected in laboratory condition
por: MORI, Hiroyuki, et al.
Publicado: (2014)

The Panther Fusion System with Open Access Functionality for Laboratory-Developed Tests for Influenza A Virus Subtyping
por: Stellrecht, Kathleen A., et al.
Publicado: (2020)

Reliability of clinical diagnosis and laboratory testing techniques currently used for identification of canine parvovirus enteritis in clinical settings
por: FAZ, Mirna, et al.
Publicado: (2016)

External Quality Assessment of SARS-CoV-2 Sequencing: an ESGMD-SSM Pilot Trial across 15 European Laboratories
por: Wegner, Fanny, et al.
Publicado: (2022)

Comparison of ePlex Respiratory Pathogen Panel with Laboratory-Developed Real-Time PCR Assays for Detection of Respiratory Pathogens
por: Nijhuis, R. H. T., et al.
Publicado: (2017)

Early Laboratory Diagnosis of COVID-19 by Antigen Detection in Blood Samples of the SARS-CoV-2 Nucleocapsid Protein
por: Thudium, Rebekka F., et al.
Publicado: (2021)

Comparison of an ID NOW COVID-19 Assay Used at the Point of Care to Laboratory-Based Nucleic Acid Amplification Tests
por: Payne, David, et al.
Publicado: (2023)

Spatial analysis of positive and negative Q fever laboratory results for identifying high- and low-risk areas of infection in the Netherlands
por: van den Berg, Elsa J., et al.
Publicado: (2013)

Analysis of sputum/tracheal aspirate and nasopharyngeal samples for SARS-CoV-2 detection by laboratory-developed test and Panther Fusion system
por: Thwe, Phyu M., et al.
Publicado: (2021)

Proficiency testing for SARS-CoV-2 in assuring the quality and overall performance in viral RNA detection in clinical and public health laboratories
por: Lau, Katherine A., et al.
Publicado: (2022)

Comparison of FilmArray Respiratory Panel and laboratory-developed real-time reverse transcription–polymerase chain reaction assays for respiratory virus detection()()
por: Renaud, Christian, et al.
Publicado: (2012)

Evaluation of serological assays available in a biosafety level 2 laboratory and their application for survey of Middle East respiratory syndrome coronavirus among livestock in Ethiopia
por: TERAMICHI, Takurou, et al.
Publicado: (2019)

Significant Improvement in Diagnosis of Hepatitis C Virus Infection by a One-Step Strategy in a Central Laboratory: an Optimal Tool for Hepatitis C Elimination?
por: López-Martínez, Rosa, et al.
Publicado: (2019)

Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal Specimens
por: Hogan, Catherine A., et al.
Publicado: (2020)

Whole-Blood Testing for Diagnosis of Acute Zika Virus Infections in Routine Diagnostic Setting
por: Voermans, Jolanda J.C., et al.
Publicado: (2019)

Comparison of Two Commercial Molecular Tests and a Laboratory-Developed Modification of the CDC 2019-nCoV Reverse Transcriptase PCR Assay for the Detection of SARS-CoV-2
por: Moore, Nicholas M., et al.
Publicado: (2020)

How many are we missing with ID NOW COVID-19 assay using direct nasopharyngeal swabs? Findings from a mid-sized academic hospital clinical microbiology laboratory
por: Thwe, Phyu M., et al.
Publicado: (2020)

Divergence of wastewater SARS-CoV-2 and reported laboratory-confirmed COVID-19 incident case data coincident with wide-spread availability of at-home COVID-19 antigen tests
por: Boehm, Alexandria B., et al.
Publicado: (2023)

Evaluating novel COVID-19 vaccines in the current chapter of the pandemic
por: GeurtsvanKessel, Corine H, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 antibodies among healthcare workers in Dutch hospitals after the 2020 first wave: a multicentre cross-sectional study with prospective follow-up
por: Recanatini, Claudia, et al.
Publicado: (2023)

Shedding of Yellow Fever Virus From an Imported Case in the Netherlands After Travel to Brazil
por: Phan, My V T, et al.
Publicado: (2020)

Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays
por: Wolff, Fleur, et al.
Publicado: (2020)

MERS coronavirus: Data gaps for laboratory preparedness
por: de Sousa, Rita, et al.
Publicado: (2014)

COVID-19 vaccine effectiveness and evolving variants: understanding the immunological footprint
por: Zaeck, Luca M, et al.
Publicado: (2023)

A line immunoassay utilizing recombinant nucleocapsid proteins for detection of antibodies to human coronaviruses
por: Lehmann, Christian, et al.
Publicado: (2008)

Two clinical cases of renal syndrome caused by Dobrava/Saaremaa hantaviruses imported to the Netherlands from Poland and Belarus, 2012–2014
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2016)

Reply to: Comment on: Zika virus and Guillain–Barré syndrome in Bangladesh
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2018)

Complete Genome Characterization of Eight Human Parainfluenza Viruses from the Netherlands
por: Phan, My V. T., et al.
Publicado: (2019)

Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2
por: Muench, Peter, et al.
Publicado: (2020)

Tropheryma whipplei aortic valve endocarditis, cured without surgical treatment
por: Algin, Ahmet, et al.
Publicado: (2012)

Acute influenza virus-associated encephalitis and encephalopathy in adults: a challenging diagnosis
por: Meijer, Wouter J., et al.
Publicado: (2016)

Proficiency Testing of Virus Diagnostics Based on Bioinformatics Analysis of Simulated In Silico High-Throughput Sequencing Data Sets
por: Brinkmann, Annika, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rhnj41fc3enp3mv42ptf21i6ln